StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Vertex Pharmaceuticals Incorporated
NasdaqGS:VRTX
Sector
Industries
Location
Market Cap
USD 123.14 B
Share Price
USD 479.53
Avg Daily Volume
1,649,161
Change (1 day)
0.12%
Change (1 year)
-2.46%
Change (YTD)
19.08%
Vertex Pharmaceuticals Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -980.30 M
Vertex Pharmaceuticals Incorporated Operating Cash Flow is USD -980.30 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -124.86% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Vertex Pharmaceuticals Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 3.94 B, a -3.18% change year over year.
-
Vertex Pharmaceuticals Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 4.07 B, a 52.07% change year over year.
-
Vertex Pharmaceuticals Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 2.68 B, a -20.25% change year over year.
-
Vertex Pharmaceuticals Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 3.36 B, a 63.03% change year over year.
Competitors
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
CSL Limited
USD 159.67
CSL.AX
+0.42
0.26%
Regeneron Pharmaceuticals, Inc.
USD 559.76
REGN
+7.18
1.30%
MERCK Kommanditgesellschaft auf Aktien
USD 133.90
MRK.DE
+3.46
2.66%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.07
0.91%
Takeda Pharmaceutical Company Limited
USD 29.72
4502.T
+0.09
0.30%
Alnylam Pharmaceuticals, Inc.
USD 322.64
ALNY
+1.77
0.55%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
CSL Limited
USD 159.67
CSL.AX
+0.42
0.26%
Regeneron Pharmaceuticals, Inc.
USD 559.76
REGN
+7.18
1.30%
MERCK Kommanditgesellschaft auf Aktien
USD 133.90
MRK.DE
+3.46
2.66%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.07
0.91%
Takeda Pharmaceutical Company Limited
USD 29.72
4502.T
+0.09
0.30%
Alnylam Pharmaceuticals, Inc.
USD 322.64
ALNY
+1.77
0.55%